Axiom Bio AI

Axiom Bio AI is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Small business

3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.

Discovery In Silico Drug Dynamics Develop In Silico model of a drug candidate with a biological system with applications such as Pro-drug Predictions, ADME-PK Due Diligence, Brain-Barrier Permeability Simulation, Drug Absorption Simulation, In Silico...

Discovery Computational Chemistry Model the interaction of a drug candidate with protein targets such as kinases, GPCRs, receptors, ion channels or enzymes.
Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
Virtual Screening Use software algorithms to virtually screen millions of potential compounds and peptides for binding.

Drug-Induced Liver Injury (DILI) Toxicity Assays Use biochemical, cell-based or in vivo assays to measure toxicity from drug-induced liver injury.

General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.

Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.

Cytotoxicity Test for effects on cell viability and proliferation
Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.

Show all 15 services 3 more

Discovery Computational Systems Biology Model the interaction of biological system with drug candidates.
Machine Learning/ AI Predict and model an outcome (e.g. disease progression) based on input variables (i.e. features.)

Work with Axiom Bio AI on Scientist.com

For prices, more details, or to contact Axiom Bio AI, visit Scientist.com.